Soligenix Announces Adjournment of Annual Meeting and Information for Reconvened Meeting
yahoo.com
news
2022-10-20 12:30:00

Meeting adjourned to November 17, 2022, at 9:00 a.m., Eastern Time

Soligenix encourages all stockholders as of record July 25, 2022, who have not yet voted, to vote by 11:59 p.m., Eastern Time on November 16, 2022

PRINCETON, N.J., Oct. 20, 2022 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that its 2022 Annual Meeting of Stockholders (the "Annual Meeting") has been further adjourned with respect to Proposal 2 (the authorized share increase), as described in the Company's definitive proxy statement filed with the U.
